AD-203
- Generic Name
- AD-203
A Study to Evaluate the Efficacy and Safety of AD-203
Phase 3
Completed
- Conditions
- Acute GastritisChronic Gastritis
- Interventions
- First Posted Date
- 2019-08-26
- Last Posted Date
- 2020-12-02
- Lead Sponsor
- Addpharma Inc.
- Target Recruit Count
- 475
- Registration Number
- NCT04066530
- Locations
- 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath